| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |